Simple research view

ZBH · Zimmer Biomet Holdings, Inc.

$92.44 -2.29% Sep 10 close

Detected setup watchlist_candidate · Setup Score 0/100

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about ZBH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$ZBH

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $18B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1

$92.44 latest close

⚠ Risk Signals

Rising Wedge prior_advance=26.1%, converging=yes, narrowing=8%, touches=upper:3/lower:3, trigger=broke

Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.

Join to Watchlist $ZBH Share card

Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $ZBH. Every level, score and criterion below is computed from the Sep 10 close session (1 session old), and may no longer hold.

Historical verdict · setup score 0/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

ZBH-2.29%

Sector proxy · XLV-0.55%

Broad market · SPY-0.60%

Same completed session window ending 2026-09-10. ZBH was -1.74 points vs XLV. -1.69 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close-2.29% From the open-1.70% Range position38% GapNo gap

QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $92.44 -2.3% Sep 10 close

52W High $106.88 11.8% below high

Wks Since High 50w 44w today

Base Depth 24.0% 26.0% today

RS Rank 1 percentile of scan

SMA 50 $95.15

Avg Vol 2,153,928

Rel Vol (Sep 10) 0.63×

More stats

52W Low $79.12

Tight Wks 1 0 today

Base B1

SMA 200 $91.43

RS Line vs High -23.8%

RS Line Slope -2.5% ▼

Group Rank #25/58

ADR% 2.6%

ATR(14) $2.77 (3.0%)

Vol Pace (live) N/A

U/D Vol 1.03

A/D Days 14A / 14D

A/D Rating C

VDU Bars 0/10 d

Position in 52-week range 48thpercentile of the 52-week range

$79.12low

$106.88high

ZBH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for ZBH.

Create Free Account

Technical Analysis Report Card

$ZBH · $92.44 · as of 2026-09-10 · multi-factor read

/ 100

Technicals 36/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▬ Sideways / consolidating

Monthly ▬ Sideways / consolidating

Moving Averages

50-day$95.15 ↓

100-day$90.75 ↑

200-day$91.43 ↑

Bullish (50 > 200)

RSI (14)

Reading36.5 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateBearish

Histogram-1.129

Bearish — MACD below its signal line and below zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-16% · 9.9%

Piercing the lower band — capitulation or strong selling.

Volume · Buyer vs Seller

Up/Down vol1.03 · Neutral

Rel volume0.63×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $93.34swing level

R · $95.40swing level

R · $97.70swing level

Price · $92.44now

S · $90.31swing level

S · $87.87swing level

S · $85.91swing level

Fibonacci · Uptrend swing

23.6%$97.26

38.2% ◄ price here$93.79

50.0%$90.99

61.8%$88.19

78.6%$84.20

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ZBH — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Above 200-day MA50/200 bullishRS 2 (laggard)

Want this read in a legend's voice? Ask a Legend about ZBH

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini C

Trend-template read: fails Price > 50-day MA.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $94.22, MA150 $91.58, MA200 $91.39

1.2 150-day MA > 200-day MAMA150 $91.58 vs MA200 $91.39

Failing evidence

1.5 Price > 50-day MAPrice $94.22 vs MA50 $94.95

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 2

6/9 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high11.8% below high | RS line new high: False

S: Volume ≥ 40% above average on breakoutVolume ratio 1.42x

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 2

C: Quarterly EPS acceleration ≥ 25%Data unavailable

3/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $94.22 vs MA200 $91.39

Failing evidence

Relative strength ≥ 60RS 2

30-week MA trending upwardData unavailable

4/6 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$94.22

Volume vs average1.42x

Failing evidence

Relative strengthRS 2

Pivotal point cleared on expanding volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$94.22

Volume vs average1.42x

Failing evidence

Relative strengthRS 2

Box top broken on heavy volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$94.22

Volume vs average1.42x

Failing evidence

Relative strengthRS 2

Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending

4/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +8 C

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met

C 2/7 criteria

Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY +7%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✗ RS rating ≥80 (leadership) 2

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -13.5%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis (historical)

watchlist_candidate

0 setup score

RS Score 2

Trend template 5/8

Why This Setup?

watchlist_candidate · schematic

Near-miss 5/8 — needs: price above sma50, price above 30pct of 52w low, rs score above 70

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met

A relative-strength leader — not met RS rank 1 — laggard
Risk is defined — not met No stop — undefined risk
Asymmetric reward — partly met No target set
Clear of earnings — partly met Report date unknown
Not chasing (in range) — partly met Pivot distance unknown
Volume confirms — partly met 0.6× average — light
In a confirmed uptrend — met Stage 2 · Trend template 5/8

Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $92.44 vs SMA150 $91.66 / SMA200 $91.43

SMA 150 above SMA 200 SMA150 $91.66 vs SMA200 $91.43

SMA 200 trending up Slope +0.50 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $95.15

Price above SMA 50 $92.44 vs SMA50 $95.15

30%+ above 52-week low +16.8% from $79.12

Within 25% of 52-week high -13.5% from $106.88

RS score above 70 RS 2

Fundamentals

52W Range

48%

Mkt Cap SEC

17.6B

Rev YoY

+7%

EPS TTM

$3.55

P/E TTM

26.0x

Float

191M

Company

Company profile

Zimmer Biomet Holdings, Inc.

ZBH · NYSE · Health Technology · Medical Specialties

Scan History

Sep 09

watchlist_candidate

Sep 08

Trend Only ✓ Gate

57 -1.9%

Sep 08

Trend Only ✓ Gate

52 -1.9%

Get the full picture on ZBH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial